Cas9-directed immune tolerance in humans—a model to evaluate regulatory T cells in gene therapy?

Abstract The dichotomic nature of the adaptive immune response governs the outcome of clinical gene therapy. On the one hand, neutralizing antibodies and cytotoxic T cells can have a dramatic impact on the efficacy and safety of human gene therapies. On the other hand, regulatory T cells (Treg) can...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Dimitrios L. Wagner, Lena Peter, Michael Schmueck‐Henneresse
Formato: Revisão
Idioma:inglés
Publicado: 2021
Acceso en liña:https://doi.org/10.1038/s41434-021-00232-2
https://www.nature.com/articles/s41434-021-00232-2.pdf
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!